Faculty of Medicine

Faculty of Medicine

Academic Members

Veysel Sabri Hançer

Veysel Sabri Hançer,  Prof.

vhancer@istinye.edu.tr
CV
Faculty Member

Professor Dr. Veysel Sabri Hançer graduated from Karşıyaka High School (Izmir, Turkey) in 1995 and Ege University Faculty of Science in 1999. After completing his Master's Degree at Ege University in 2001, he completed his PhD in 2009 at Istanbul University Molecular Biology and Genetics program. He studied at Molecular Hematology laboratory in Istanbul University between 2001 and 2010. Dr.Hancer received his Associate Professor and Professor degrees in 2013 and 2018 respectively. He is currently the head of the Department of Medical Biology, Faculty of Medicine, Istinye University. He is the author of numerous international scientific articles and national / international awards with h-index of 13. His research intrests are cancer genetics and thrombosis genetics. He is a member of the Editorial Board of the Journal of Human Genetics & Embriology and the editor of the Turkish Journal of Hematology. Dr.Hancer is a member of Turkish Hematology Association and Medical Biology and Genetics Association. He speaks English and is married with two children.

Research Areas: Cancer Biology, Thrombosis

Main Areas: Tıbbi Biyoloji, 

2019 - Novel Pathological Mutation (c.870 GA, p.Trp290stop) in ARSB of Mucopolysaccharidosis Type VI Patients
HANÇER VEYSEL SABRİ,BÜYÜKDOĞAN MURAT,Babameto laku Anila. Molecular Syndromology, 75-76.
2019 - Case report of a young patient with transthyretin amyloidosis associated with Gly67Ala mutation
Salihoglu Ayse,YILDIRIM SÜLEYMAN,AR MUHLİS CEM,HANÇER VEYSEL SABRİ,BOZCAN SELMA,YILMAZ UMUT,serin nergis,tüzüner nükhet. Amyloid, 26(sup1), 75-76.
2019 - Kruppel-Like Transcription Factor-4 Gene Expression and DNA Methylation Status in Type 2 Diabetes and Diabetic Nephropathy Patients
coskun zeynep mine,ersoz melike,Adas Mine,HANÇER VEYSEL SABRİ,boysan serife nur,GÖNEN MUSTAFA SAİT,ACAR AYNUR. Archives of Medical Research, 50(3), 91-97.
2019 - Evaluation of Tissue Factor -603 A/G Promoter Gene Polymorphism in Thrombotic Processes in Patients with Antiphospholipid Syndrome
KAHRAMAN RESUL,HANÇER VEYSEL SABRİ,ERGEN HAYRİYE ARZU,ÇAKMAKOĞLU BEDİA,KÜÇÜKKAYA DİZ REYHAN. Experimed, 9(1), 1-6.
2018 - Prevalence of human papilloma virus types in Turkish and Albanian women
HANÇER VEYSEL SABRİ, BÜYÜKDOĞAN MURAT, BYLYKBASHI ILTA, ÖKSÜZ BURCU, ACAR MURADİYE. Journal of Cytology, 35(4), 252-254.
2018 - Prognostic significance of carbonic anhydrase IX overexpression in stage III non-small cell lung cancer patients after neoadjuvant treatment
İBİŞ KAMURAN,SAĞLAM SEZER,FIRAT PINAR,YILMAZBAYHAN EMİNE DİLEK,TOKER SEYFİ ALPER,KAYTAN SAĞLAM ESRA,ÖZKAN BERKER,HANÇER VEYSEL SABRİ,BÜYÜKDOĞAN MURAT,DİŞÇİ RİAN,KEZBAN PİLANCI. Pathology - Research and Practice, 214(9), 1291-1296.
2018 - A novel ATP6V0A2 mutation causing recessive cutis laxa with unusual manifestations of bleeding diathesis and defective wound healing
KARACAN İLKER,Diz Küçükkaya Reyhan,karakuş Fatma Nur,SOLAKOĞLU SEYHUN,Tolun Aslıhan,HANÇER VEYSEL SABRİ,TAHİR TURANLI EDA. Turkish Journal of Hematology,
2018 - β globin mutations in Turkish, Northern Iraqi and Albanian patients with β thalassemia major
HANÇER VEYSEL SABRİ,FIŞGIN TUNÇ,BÜYÜKDOĞAN MURAT,BOZKURT CEYHUN,lako sotiraq. Thalassemia Reports, 8(2), 97-100.
2018 - Three Factor 11 mutations associated with Factor XI deficiency in a Turkish family
HANÇER VEYSEL SABRİ,gökgöz zafer,BÜYÜKDOĞAN MURAT. Turkish Journal of Hematology, 35(1), 79-80.
2017 - A Novel Ganciclovir Resistance Mutation in the UL97 Gene of the HHV-5 in an Adult Hematopoietic Stem Cell Transplant Recipient
HANÇER VEYSEL SABRİ, SAĞLAM FİLİZ, BÜYÜKDOĞAN MURAT, AKI ŞAHİKA ZEYNEP, ÖKSÜZ BURCU, ACAR KADİR, ACAR MURADİYE, BULUT PELİN. Future Virology, 12(12), 761-766.
2017 - Pharmacogenetic Aspect of Intravitreal Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Five-Year Follow-Up
ŞENGÜL ELVAN ALPER,ARTUNAY HALİL ÖZGÜR,RASİER RIFAT,KOÇKAR ALEV,afacan ceyda,HANÇER VEYSEL SABRİ,YÜZBAŞIOĞLU ERDAL. ocular immunology and inflammation, 26(6), 971-977.
2017 - Three Novel Calreticulin Mutations in Two Turkish Patients
HANÇER VEYSEL SABRİ,TOKGÖZ HÜSEYİN,GÜVENÇ SERKAN,ÇALIŞKAN ÜMRAN,BÜYÜKDOĞAN MURAT. Turkish Journal of Hematology, 34(4), 360-361.
2016 - P-selectin glycoprotein ligand-1 variable number of tandem repeats polymorphism in young myocardial infarction patients
çağlar fatma nilhan turhan,bıyık ismail,IŞIKSAÇAN NİLGÜN,HANÇER VEYSEL SABRİ,aktürk faruk,çiftçi serkan,ungan ismail,şahin alparslan. Archives of Medical Science - Civilization Diseases, 1(1), 112-113.
2016 - Glycoprotein Ibα Kozak polymorphism in patients presenting with early-onset acute coronary syndrome.
golcuk ebru,YALIN KIVANÇ,AKDENİZ CANSU SELCAN,teker erhan,TEKER AYŞEGÜL BAŞAK,HANÇER VEYSEL SABRİ,ALTUN İBRAHİM,küçükkaya reyhan,ÖNCÜL AYTAÇ. Archives of Medical Science, 14(4), 788-793.
2016 - Dual effects of testosterone in Behcet s disease implications for a role in disease pathogenesis
YAVUZ ŞULE,akyıldız tuba,HANÇER VEYSEL SABRİ,BIÇAKÇIGİL KALAYCI MÜGE,can meryem,DEMİREL GÜLDEREN. Genes & Immunity, 17(6), 335-341.
2015 - Prophylactic Eculizumab Use in Kidney Transplantation A Review of the Literature and Report of a Case with Atypical Hemolytic Uremic Syndrome
kasapoğlu umut,çağlar ruhi,tuğcu murat,Boynueğri başak,titiz izzet,HANÇER VEYSEL SABRİ,APAYDIN SÜHEYLA. Annals of Transplantation, 20(1), 714-719.
2015 - Non invasive prenatal diagnosis of fetal RhD by using free fetal DNA
gönenç gökçe,işçi herman,BAŞGÜL YİĞİTER ALİN,HANÇER VEYSEL SABRİ,büyükdoğan murat,güdücü nilgün,dünder ilkkan. Clinical and experimental obstetrics & gynecology, 42(3), 344-346.
2014 - Renal outcome with eculizumab in two diarrhea-associated haemolytic-uremic syndrome cases with severe neurologic involvement.
ekinci zelal,BEK KENAN,aytaç mehmet baha,KARADENİZLİ AYNUR,HANÇER VEYSEL SABRİ. hong kong journal of nephrology, 16(2), 46-49.
2014 - The Relationship between P Selectin Polymorphisms and Thrombosis in Antiphospholipid Syndrome A Pilot Case Control Study
alpay nilüfer,HANÇER VEYSEL SABRİ,erer burak,İNANÇ MURAT,diz küçükkaya reyhan. turkish journal of hematology, 31(4), 357-362.
2014 - Coronary artery ectasia is associated with the c 894G T Glu298Asp polymorphism of the endothelial nitric oxide synthase gene
yalçın ahmet arif,aktürk ibrahim faruk,çelik ömer,ertürk mehmet,HANÇER VEYSEL SABRİ,yalçın burce,ışıksaçan nigün,uzun fatih,özbey özyılmaz sinem,bıyık ismail. The Tohoku Journal of Experimental Medicine, 232(2), 137-144.
2013 - MPL W515L K mutations in chronic myeloproliferative neoplasms
akpınar timur selçuk,HANÇER VEYSEL SABRİ,NALÇACI MELİHA,diz küçükkaya reyhan. turkish journal of hematology, 30(2), 8-12.
2013 - Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab
gulleroglu k, fidan k, hancer vs, Bayrakci U, Baskin E, Soylemezoglu O. Pediatr Nephrol, 28(5), 827-830.
2012 - Eculizumab therapy in a child with hemolytic uremic syndrome and CFI mutation
cayci fs, cakar n, hancer vs, Uncu N, Acar B, Gur G. Pediatr Nephrol, 27(12), 2327-2331.
2012 - The clinical significance of JAK2V617F mutation for Philadelphia negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis
yonal i, pinarbasi b, hindilerden f, Hancer VS, Nalcaci M, Kaymakoglu S, Diz Kucukkaya R. J Thromb Thrombolysis, 34(3), 388-396.
2012 - Glycoprotein Ib alpha Kozak polymorphism in ischemic stroke
esen fi, hancer vs, kucukkaya rd, Yeşilot N, Coban O, Bahar S, Tuncay R. Neurol Res, 34(1), 68-71.
2012 - The impact of platelet membrane glycoprotein Ib alpha and Ia IIa polymorphisms on the risk of thrombosis in the antiphospholipid syndrome
yonal i, hindilerden f, hancer vs, Artim Esen B, Daglar A, Akadam B, Nalcaci M, DizKucukkaya R. Thromb Res, 129(4), 486-491.
2012 - Chronic lymphocytic leukemia developing in a patient with Janus kinase 2 V617F mutation positive myeloproliferative neoplasm
eskazan ae, salihoglu a, diz kucukkaya r, hancer vs, soysal t. Ann Hematol, 92(2), 305-306.
2012 - Overexpression of Fc Mu Receptor FCMR TOSO Gene In Chronic Lymphocytic Leukemia Patients
hancer vs, diz kucukkaya r, aktan m. medical oncology, 29(2), 1068-1072.
2011 - ADAMTS 13 gene expression in antiphospholipid syndrome
hancer vs, diz kucukkaya r, topal sarikaya a. Turk J Hematol, 28(1), 213-218.
2011 - Comparison of KRAS Mutation Tests in Colorectal Cancer Patients
hancer vs, buyukdogan m, turkmen i, Bassullu N, Altug T, DizKucukkaya R, Bulbul Dogusoy G, Demir G. Genet Test Mol Biomarkers, 15(11), 831-834.
2011 - Polymorphisms of the angiotensin converting enzyme and angiotensinogen gene in patients with atrial fibrillation
topal np, ozben b, hancer vs, Tanrikulu AM, DizKucukkaya R, Fak AS, Basaran Y, Yesildag O. J Renin Angiotensin Aldosterone Syst, 12(4), 549-556.
2011 - Activation induced cytidine deaminase mRNA levels in chronic lymphocytic leukemia
hancer vs, kose m, diz kucukkaya r, Yavuz AK, Aktan M. Leuk Lymph, 52(1), 79-84.
2010 - Cytotoxic T Lymphocyte Antigen 4 CTLA 4 A49G Polymorphism and Autoimmune Blood Diseases
akturk f, hancer vs, diz kucukkaya r. Turk J Hematol, 27(2), 78-81.
2010 - Impact of genetic polymorphisms on platelet function and aspirin resistance
pamukcu b, oflaz h, onur i, Hancer V, Yavuz S, Nisanci Y. Blood Coagul Fibrinolysis, 21(1), 53-56.
2010 - The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndrome
diz kucukkaya r, hancer vs, artim esen b, Pekcelen Y, Inanc M. J Thromb Thrombolysis, 29(3), 303-309.
2008 - Angiotensin converting enzyme gene polymorphism in arrhythmogenic right ventricular dysplasia is DD genotype helpful in predicting syncope risk
ozben b, altun i, hancer v, Bilge AK, Tanrikulu AM, DizKucukkaya R, Fak AS, Yilmaz E, Adalet K. J Renin Angiotensin Aldosterone Syst, 9(4), 215-220.
2007 - The association of P selectin glycoprotein ligand 1 VNTR polymorphisms with coronary stent restenosis
ozben b, diz kucukkaya r, bilge ak, hancer vs, oncul a. J Thromb Thrombolysis, 23(3), 181-187.
2006 - The association between factor XIII Val34Leu polymorphism and early myocardial infarction
hancer vs, diz kucukkaya r, bilge ak, Ozben B, Oncul A, Ergen G, Nalcaci M. circulation journal, 70(3), 239-242.
2005 - Turkish population data on the factor XIII Val34Leu glycoprotein GP Ib Kozak and P selectin glycoprotein ligand 1 PSGL 1 loci
hancer vs, diz kucukkaya r, nalcaci m. cell biochemistry and function, 23(1), 55-58.
2004 - Factor XIII Val34Leu polymorphism does not contribute to the prevention of trombotic complication in patients with antiphospholipid syndrome
Hancer VS, Nalcaci M, Inanc M, Pekcelen Y. lupus, 13(1), 32-35.
(2002), "en iyi çalışma ödülü", "Sivil Toplum Kuruluşu", "29. Ulusal Hematoloji Kongresinde ‘Antifosfolipid sendromunda faktör XIII Val34Leu polimorfizminin tromboz gelişimindeki rolü’ başlıklı çalışma ile ",
(2003), "Genç Katılımcı Ödülü", "Sivil Toplum Kuruluşu", "30. Ulusal Hematoloji Kongresinde ‘Genç yaşta koroner arter trombozu gelişen olgularda faktör XIII Val34Leu polimorfizminin katkısının araştırılması’ başlıklı çalışma ile ",
(2004), "en iyi çalışma ödülü", "Sivil Toplum Kuruluşu", "31. Ulusal Hematoloji Kongresinde ‘Faktör XIII Val34Leu, P- selektin glikoprotein ligand 1 ve glikoprotein Ib Kozak polimorfizm sıklıklarının araştırılması’ başlıklı çalışma ile",
(2004), "genç katılımcı ödülü", "Sivil Toplum Kuruluşu", "31. Ulusal Hematoloji Kongresinde ‘Faktör XIII Val34Leu, P- selektin glikoprotein ligand 1 ve glikoprotein Ib Kozak polimorfizm sıklıklarının araştırılması’ başlıklı çalışma ile",
(2004), "başarılı araştırıcı ödülü", "Üniversite", "İSTANBUL ÜNİVERSİTESİ",
(2005), "bilimsel yayınları teşvik programı ödülü", "Kamu", "TÜBİTAK",
(2006), "en iyi çalışma ödülü", "Sivil Toplum Kuruluşu", "33.Ulusal Hematoloji Kongresinde ‘Otoimmün Kan Hastalıklarında ve Kronik Lenfositik Lösemide CTLA-4 A49G Polimorfizmi’ başlıklı çalışma ile En iyi çalışma ödülü",
(2008), "genç katılımcı ödülü", "Sivil Toplum Kuruluşu", "34.Ulusal Hematoloji Kongresinde ‘Primer Antifosfolipid sendromunda ADAMTS-13 geninin mutasyonları ve transkripsiyon analizi’ başlıklı çalışma ile ",
(2010), "en iyi çalışma ödülü", "Sivil Toplum Kuruluşu", "36.Ulusal Hematoloji Kongresinde ‘Antifosfolipid sendromunda trombosit membran glikoprotein polimorfizmlerinin sıklığı ve klinik etkileri’ başlıklı çalışma ile",
(2021), "Kruppel Like Factor 4 Gene Expression and DNA Methylation in Patinet with Type 2 Diabetes and Diabetic Nephropathy", "Uluslararası", "Sağlık Bilimleri Temel Alanı->Tıbbi Biyoloji",
(2015), "Two novel calreticulin mutations in a turkish patient with primary myelofibrosis: c.1116delA and c.1120A>C.", "Uluslararası", "Sağlık Bilimleri Temel Alanı->Hematoloji",
(2015), "Two Pediatric Cases of Essential Thrombocytopenia Characterized By Extremely Rare Mutations.", "Uluslararası", "Sağlık Bilimleri Temel Alanı->Hematoloji",
(2014), "The impact of prothrombotic mutations, PSGL-1 VNTR polymorphism, tissue factor and soluble P-selectin on venous thromboembolism in cancer patients with adenocarcinoma.", "Uluslararası", "Sağlık Bilimleri Temel Alanı->Tıbbi Genetik",
(2013), "Is the Glu298Asp polymorphism of Endothelial Nitric Oxide Synthesis Increase the Risk of Stent Thrombosis?", "Uluslararası", "Sağlık Bilimleri Temel Alanı->Kardiyoloji",
(2013), "Investigation of Arrhythmia Markers and KCNJ8-S422L Gene Mutation in a Population with Early Repolarization Pattern on ECG", "Uluslararası", "Sağlık Bilimleri Temel Alanı->Kardiyoloji",
(2011), "The clinical significance of JAK2 V617F mutation for Philedelphia-negative chronic myeloproliferative diseases in patients with splanchnic vein thrombosis", "Uluslararası", "Sağlık Bilimleri Temel Alanı->Hematoloji",
(2010), "Frequency and clinical outcomes of platelet membrane glycoprotein polymorphisms in antiphospholipid syndrome.", "Uluslararası", "Sağlık Bilimleri Temel Alanı->Hematoloji",
(2009), "Tissue factor -603A/G polymorphism and tissue factor levels in patients with antiphospholipid syndrome.", "Uluslararası", "Sağlık Bilimleri Temel Alanı->Hematoloji",
(2008), "ADAMTS-13 Gene Mutations and Transcription Analysis in Primary Antiphospholipid Syndrome", "Uluslararası", "Sağlık Bilimleri Temel Alanı->Hematoloji",
(2007), "P-selectin glycoprotein ligand 1 VNTR polymorphisms in systemic sclerosis", "Uluslararası", "Sağlık Bilimleri Temel Alanı->Hematoloji",
(2006), "The association between factor XIII Val34Leu polymorphism and early myocardial infarction", "Uluslararası", "Sağlık Bilimleri Temel Alanı->Hematoloji",
"CTLA-4 A49G polymorphism and autoimmune blood diseases", "Uluslararası", "Sağlık Bilimleri Temel Alanı->Hematoloji",
"CTLA-4 A49G polymorphism and autoimmune blood diseases", "Uluslararası", "Sağlık Bilimleri Temel Alanı->Hematoloji",
(2013), "The effect of stem cell transplantation on social and economic status in a developing country on family basis", "Uluslararası", "Sağlık Bilimleri Temel Alanı->Hematoloji",
(2013), "HLA Full Match Donors.", "Uluslararası", "Sağlık Bilimleri Temel Alanı->Hematoloji",
(2013), "Factor XIII Val34Leu polymorphism does not affect the risk for thrombotic complications in patients with antiphospholipid syndrome", "Uluslararası", "Sağlık Bilimleri Temel Alanı->Hematoloji",